KPIs & Operating Metrics(New)
Advance Purchase Agreements (Apas)Breakdown Of AssetsCollabration Revenue By CategoryCollabration Revenue By Category AnnualCost Of SalesDeferred Revenue By SegmentDoses DeliveredEmployee StatisticsGrant Revenue By Category AnnualGrant Revenue By CategoyGross Margin %Gross ProfitIncome (Loss) Before Income Tax By RegionManufacturing Technology Center (Mtc)Operating Expense As A % Of Total Revenue %Operating Expense SegregationProduct Revenue By Geography %Product Revenue By Geography Annual %Product Sales By GeographyProduct Sales By Geography AnnualProfitabilityProfitability %Profitability AnnualProfitability Annual %Property And Equipment BreakdownProperty And Equipment By GeographyPurchase CommitmentsRemaining Performance ObligationRemaining Performance ObligationsRevenue By Major CustomersRevenue By Major Customers %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Total Contractual Obligations AnnualTotal Deferred Revenue
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Gross Profit (2020 - 2025)

Historic Gross Profit for Moderna (MRNA) over the last 6 years, with Q3 2025 value amounting to $809.0 million.

  • Moderna's Gross Profit fell 3998.52% to $809.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 6796.55%. This contributed to the annual value of $1.8 billion for FY2024, which is 1777.26% down from last year.
  • Moderna's Gross Profit amounted to $809.0 million in Q3 2025, which was down 3998.52% from $23.0 million recorded in Q2 2025.
  • In the past 5 years, Moderna's Gross Profit registered a high of $6.3 billion during Q4 2021, and its lowest value of -$410.0 million during Q3 2023.
  • In the last 5 years, Moderna's Gross Profit had a median value of $1.3 billion in 2024 and averaged $1.8 billion.
  • Its Gross Profit has fluctuated over the past 5 years, first surged by 2170000.0% in 2021, then crashed by 11810.95% in 2023.
  • Over the past 5 years, Moderna's Gross Profit (Quarter) stood at $6.3 billion in 2021, then plummeted by 49.42% to $3.2 billion in 2022, then crashed by 40.56% to $1.9 billion in 2023, then tumbled by 87.94% to $227.0 million in 2024, then surged by 256.39% to $809.0 million in 2025.
  • Its last three reported values are $809.0 million in Q3 2025, $23.0 million for Q2 2025, and $18.0 million during Q1 2025.